Company InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Pharmaceuticals

Delayed Canadian Securities Exchange 09:30:00 2023-12-04 am EST Intraday chart for InnoCan Pharma Corporation 5-day change 1st Jan Change
0.32 CAD 0.00% -5.88% +48.84%

Business Summary

Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.

Sales per Business

CAD in Million2021Weight2022Weight Delta
Cannabidiol-integrated Pharmaceuticals
100.0 %
0 100.0 % 3 100.0 % +1,255.72%

Sales per region

CAD in Million2021Weight2022Weight Delta
United States
94.5 %
0 17.3 % 3 94.5 % +7,281.67%
United Kingdom
3.2 %
-- 0 3.2 % -
Rest of the World
2.3 %
0 20.9 % 0 2.3 % +49.43%

Managers

Managers TitleAgeSince
Founder 70 -
Founder - 2018
Founder 58 2018
Director of Finance/CFO - -
Chief Operating Officer - 2022
Director/Board Member 58 2019

Members of the board

Members of the board TitleAgeSince
Founder 58 2018
Director/Board Member 63 2020
Chairman 59 2014
Founder - 2018
Director/Board Member 58 2019
Director/Board Member - 2019
Director/Board Member 36 2019

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 252,044,052 210,103,934 ( 83.36 %) 0 83.36 %

Shareholders

NameEquities%Valuation
Solsken Ltd.
18.95 %
49,726,311 18.95 % 11 M $
5,160,000 1.966 % 1 M $
2,859,750 1.090 % 634 865 $
Eyal Flom
0.7001 %
1,837,500 0.7001 % 407 925 $
PP-Asset Management GmbH
0.2012 %
528,000 0.2012 % 117 216 $
200,000 0.0762 % 44 400 $
Peter Bloch
0.000000 %
0 0.000000 % - $
Ralph Bossino
0.000000 %
0 0.000000 % - $
0 0.000000 % - $
Roni Kamhi
0.000000 %
0 0.000000 % - $

Company contact information

InnoCan Pharma Corp.

525-8th Avenue SW Suite 2400

T2P 1G1, Calgary

+403-777-1519

http://www.innocanpharma.com
address InnoCan Pharma Corporation(INNO)
As early as today, start finding the best investment opportunities!
Optimize my profits
fermer